Streetbeat News

Revenues

AAPL

INDA

Apple's supplier Pegatron has suspended iPhone production at its facility near Chennai, India, due to heavy rains, according to sources cited by Reuters.

Portfolio Pulse from Charles Gross

December 04, 2023 | 12:24 pm

FAMI

Farmmi, Inc. has announced a new order for its dried Shiitake mushrooms, which are to be shipped to Canada. The financial terms of the deal were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:21 pm

GP

GreenPower Motor Company Inc. has received its first order for the Nano BEAST all-electric school buses destined for the New York market, facilitated by its dealer Leonard Bus Sales. This marks a significant step for GreenPower in expanding its presence in the electric school bus segment, particularly in New York, which is a key market for electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:17 pm

SAIC

Science Applications International Corp (SAIC) reported net bookings of $2.5 billion, indicating a strong book-to-bill ratio of 1.3. The company's estimated backlog stands at $23.1 billion, suggesting a healthy pipeline of future revenue.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:08 pm

LLY

NVO

RHHBY

Roche Holding AG (OTC:RHHBY) is set to acquire Carmot Therapeutics to enter the competitive weight loss drug market, challenging Novo Nordisk (NYSE:NVO) and Eli Lilly (NYSE:LLY). Carmot's portfolio includes several incretin-based treatments for obesity and type 2 diabetes, with the lead asset CT-388 ready for Phase-2 trials. Roche will pay $2.7 billion in cash plus up to $400 million in milestone payments. The acquisition will also give Roche access to Carmot's discovery platform, enhancing its R&D in metabolism-related diseases. The deal is expected to close in Q1 2024.

Portfolio Pulse from Vandana Singh

December 04, 2023 | 12:04 pm

APLM

Apollomics has presented efficacy and safety data from the ongoing KUNPENG and SPARTA trials of Vebreltinib at the IASLC North America Conference on Lung Cancer. The data is significant for the continued development and potential future approval of Vebreltinib for treating lung cancer.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:04 pm

RDHL

RedHill Biopharma has secured approximately $4.8 million in non-dilutive external funding for the Phase 2 study of RHB-107, a COVID-19 treatment. The study, which has FDA clearance, will enroll its first patient soon and is expected to be completed by the end of 2024. It will take place in the U.S., Thailand, Ivory Coast, South Africa, and Uganda.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 12:03 pm

ASXC

Asensus Surgical has sold a Senhance Surgical System to its distribution partner, which will be placed in a hospital in the Commonwealth of Independent States (CIS) region. This sale marks the second system sold to the CIS region in the past month.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:56 am

GNL

Global Net Lease (GNL) has completed around 1.7 million square feet of leasing activity since September 30, 2023. This includes over 313,000 square feet of multi-tenant assets and nearly 1.4 million square feet of single-tenant assets.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 11:11 am

GERN

Geron Corporation announced the publication of results from the IMerge Phase 3 trial of Imetelstat versus placebo in The Lancet. The trial focused on patients with lower-risk Myelodysplastic Syndromes who are relapsed/refractory or ineligible for erythropoiesis-stimulating agents.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 10:02 am